Cambridge Investment Research Advisors’s Gain Therapeutics GANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$323K	Buy	179,500 +120,000	+202%	+$216K	﹤0.01%	2917
2025 Q1	$114K	Buy	59,500 +5,000	+9%	+$9.58K	﹤0.01%	3336
2024 Q4	$118K	Buy	+54,500	New	+$118K	﹤0.01%	3306